Influence of the organic anion transporting polypeptide 1B1 (OATP1B1) polymorphisms on irinotecan-pharmacokinetics and clinical outcome of patients with advanced non-small cell lung cancer

被引：0
|
作者：
Han, Ji-Youn [1 ]
Lim, Hyeong-Seok [1 ]
Lee, Sung Young [1 ]
Kim, Heung Tae [1 ]
Lee, Jin Soo [1 ]
机构：
[1] Natl Canc Ctr, Goyang, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2007年 / 2卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S485 / S485
页数：1
相关论文
共 50 条
  • [31] Flavonoids as a novel class of human organic anion-transporting polypeptide OATP1B1 (OATP-C) modulators
    Wang, XD
    Wolkoff, AW
    Morris, ME
    DRUG METABOLISM AND DISPOSITION, 2005, 33 (11) : 1666 - 1672
  • [32] Organic anion transporting polypeptide 1B1 activity classified by SLCO1B1 genotype influences atrasentan pharmacokinetics
    Katz, DA
    Carr, R
    Grimm, DR
    Xiong, H
    Holley-Shanks, R
    Mueller, T
    Leake, B
    Wang, Q
    Han, LX
    Wang, PG
    Edeki, T
    Sahelijo, L
    Doan, T
    Allen, A
    Spear, BB
    Kim, RB
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (03) : 186 - 196
  • [33] Influence of Rifampin-Mediated Organic Anion-Transporting Polypeptide 1B1/1B3 Inhibition on the Pharmacokinetics of Clazosentan
    Juif, Pierre-Eric
    Voors-Pette, Christine
    Ufer, Mike
    Dogterom, Peter
    Dingemanse, Jasper
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2019, 12 (05): : 440 - 444
  • [34] Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer
    Han, Ji-Youn
    Lim, Hyeong-Seok
    Lee, Sung Young
    Lee, Dae Ho
    Kim, Heung Tae
    Lee, Jin Soo
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S485 - S485
  • [35] Schisandrin A and B induce organic anion transporting polypeptide 1B1 transporter activity
    Guo, Cheng-Xian
    Deng, Sheng
    Yin, Ji-Ye
    Liu, Zhao-Qian
    Zhang, Wei
    Zhou, Hong-Hao
    PHARMAZIE, 2015, 70 (01): : 29 - 32
  • [36] Cytochrome P450 1B1 (CYP1B1) polymorphisms are associated with clinical outcome of docetaxel in non-small cell lung cancer (NSCLC) patients
    Enrico Vasile
    Carmelo Tibaldi
    G. Leticia Leon
    Armida D’Incecco
    Elisa Giovannetti
    Journal of Cancer Research and Clinical Oncology, 2015, 141 : 1189 - 1194
  • [37] Cytochrome P450 1B1 (CYP1B1) polymorphisms are associated with clinical outcome of docetaxel in non-small cell lung cancer (NSCLC) patients
    Vasile, Enrico
    Tibaldi, Carmelo
    Leticia Leon, G.
    D'Incecco, Armida
    Giovannetti, Elisa
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (07) : 1189 - 1194
  • [38] Inhibition of human organic anion transporting polypeptide OATP 1B1 as a mechanism of drug-induced hyperbilirubinemia
    Campbell, SD
    de Morais, SM
    Xu, JHJ
    CHEMICO-BIOLOGICAL INTERACTIONS, 2004, 150 (02) : 179 - 187
  • [39] Identification of Novel Inhibitors of Organic Anion Transporting Polypeptides 1B1 and 1B3 (OATP1B1 and OATP1B3) Using a Consensus Vote of Six Classification Models
    Kotsampasakou, Eleni
    Brenner, Stefan
    Jaeger, Walter
    Ecker, Gerhard F.
    MOLECULAR PHARMACEUTICS, 2015, 12 (12) : 4395 - 4404
  • [40] The Effect of Original Russian Neurotropic Drugs on Organic Anion Transporting Polypeptides OATP1B1 and OATP1B3
    P. D. Erokhina
    Yu. V. Abalenikhina
    P. Yu. Mylnikov
    A. V. Petrov
    S. O. Ganina
    E. A. Konyakhin
    A. V. Shchulkin
    E. N. Yakusheva
    Bulletin of Experimental Biology and Medicine, 2023, 176 : 170 - 175
12345